DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "The Overview of Japanese Pharmaceutical Industry ver 2016" report to their offering.
This report talks about the overview of Japanese pharmaceutical industry. By reading this report, readers will understand overall picture about the industry, from various aspects.
Domestic pharmaceutical market size is said to be about 6.9 trillion yen at the ex-manufacturer level, and about 10.8 trillion yen in terms of drug price. While the market size of non-prescription drugs is slightly declining, that of ethical drugs is on the rise, accounting for about 90% of the whole market.
Key Topics Covered:
1. Summary
2. Definition of pharmaceutical industry
3. Classification of pharmaceutical industry
4. Definition of drugs
5. Distribution structure of drugs
6. Pharmaceutical market size in Japan
7. Regulation of related laws
8. Related industry groups
9. High profitability
10. Long history and family management
11. Difficulty of new drug development
12. Structural risk peculiar to the pharmaceutical industry, Patent cliff
13. Disclosure of pipeline
14. Low penetration of vertical integration
15. Changing business environment
16. Companies striving for structural reform
17. Differences between Japanese and foreign companies
18. Characteristics of Labour market
19. Concentration of major companies in member countries of the Organization for Economic Co-operation and Development (OECD)
20. Reference: Comparison with the U.S. and European countries
For more information about this report visit http://www.researchandmarkets.com/research/zhswrf/the_overview_of
